← Every company
Ultragenyx Pharmaceutical Inc SEC Filings
What Ultragenyx Pharmaceutical Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
RARE overview →Filings on file
136
since Nov 7, 2016
Warning signs
0
none filed
Last results
Aug 4, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 4, 2026 | Results announced 8-K | Read ↗ |
| May 5, 2026 | Results announced 8-K | Read ↗ |
| Feb 12, 2026 | Results announcedRestructuring 8-K | Read ↗ |
| Jan 12, 2026 | Results announced 8-K | Read ↗ |
| Nov 4, 2025 | Results announcedMaterial agreement 8-K | Read ↗ |
| Aug 5, 2025 | Results announced 8-K | Read ↗ |
| May 6, 2025 | Results announced 8-K | Read ↗ |
| Feb 13, 2025 | Results announced 8-K | Read ↗ |
| Jan 13, 2025 | Results announced 8-K | Read ↗ |
| Nov 5, 2024 | Results announced 8-K | Read ↗ |
| Aug 1, 2024 | Results announced 8-K | Read ↗ |
| May 2, 2024 | Results announced 8-K | Read ↗ |
| Feb 15, 2024 | Results announced 8-K | Read ↗ |
| Jan 8, 2024 | Results announced 8-K | Read ↗ |
| Nov 2, 2023 | Results announced 8-K | Read ↗ |
| Oct 16, 2023 | Results announced 8-K | Read ↗ |
| Aug 3, 2023 | Results announced 8-K | Read ↗ |
| May 4, 2023 | Results announced 8-K | Read ↗ |
| Feb 16, 2023 | Results announced 8-K | Read ↗ |
| Jan 6, 2023 | Results announced 8-K | Read ↗ |
| Nov 2, 2022 | Results announced 8-K | Read ↗ |
| Jul 28, 2022 | Results announced 8-K | Read ↗ |
| May 5, 2022 | Results announced 8-K | Read ↗ |
| Feb 10, 2022 | Results announced 8-K | Read ↗ |
| Jan 10, 2022 | Results announced 8-K | Read ↗ |
| Nov 2, 2021 | Results announced 8-K | Read ↗ |
| Aug 2, 2021 | Results announced 8-K | Read ↗ |
| May 4, 2021 | Results announced 8-K | Read ↗ |
| Feb 11, 2021 | Results announced 8-K | Read ↗ |
| Jan 11, 2021 | Results announced 8-K | Read ↗ |
| Oct 27, 2020 | Results announced 8-K | Read ↗ |
| Jul 30, 2020 | Results announced 8-K | Read ↗ |
| May 6, 2020 | Results announced 8-K | Read ↗ |
| Feb 13, 2020 | Results announced 8-K | Read ↗ |
| Jan 13, 2020 | Results announced 8-K | Read ↗ |
| Nov 5, 2019 | Results announced 8-K | Read ↗ |
| Aug 1, 2019 | Results announced 8-K | Read ↗ |
| May 6, 2019 | Results announced 8-K | Read ↗ |
| Feb 19, 2019 | Results announced 8-K | Read ↗ |
| Nov 5, 2018 | Results announced 8-K | Read ↗ |
| Aug 2, 2018 | Results announced 8-K | Read ↗ |
| May 7, 2018 | Results announced 8-K | Read ↗ |
| Feb 20, 2018 | Results announced 8-K | Read ↗ |
| Nov 2, 2017 | Results announced 8-K | Read ↗ |
| Jul 27, 2017 | Results announced 8-K | Read ↗ |
| May 4, 2017 | Results announced 8-K | Read ↗ |
| Feb 16, 2017 | Results announced 8-K | Read ↗ |
| Nov 7, 2016 | Results announced 8-K | Read ↗ |
Source: Ultragenyx Pharmaceutical Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on RARE
Company overviewEverything on RARE in one place, with the price.Insider tradingWhat RARE's own officers and directors buy and sell.Planned salesSales RARE insiders have filed notice of.Who owns itEvery manager reporting a position in RARE.Funds holding itWhich funds and ETFs hold RARE, and how big a bet.LobbyingWhat RARE spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on RARE's account, and who they worked for.PatentsWhat RARE is filing at the patent office.